Wed Dec 22, 2021 – 8:07 am EST
This story was originally published by the WND News Center
(WND News Center) – The new omicron variant that is causing renewed panic among government officials and media could turn out to be “a Christmas present,” says the inventor of the mRNA technology behind the Pfizer and Moderna COVID-19 vaccines.
Dr. Robert W. Malone, in a video interview Monday with WND, explained that while the original SARS-CoV-2 virus settled in the lungs, a new University of Hong Kong study that is still under peer review is among other studies indicating that omicron is settling in the upper respiratory tract. That makes it more transmissible but less virulent.
Consequently, the new variant, which was first detected in South Africa on Nov. 25, could act similarly to a live attenuated virus vaccine, producing mild symptoms and natural immunity to COVID-19, Malone said.
He urged caution, noting a pre-print U.K. study by Imperial College of London reporting it is finding no difference in omicron hospitalizations compared to delta. However, the U.K. researchers acknowledged in their initial report that hospitalization data “remains very limited at this time.”
In fact, South African officials reported last week that only 1.7% of
The remainder of this article is available in its entirety at LifeSite News
The views expressed in this news alert by the author do not directly represent that of The Official Street Preachers or its editors